KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $136.5 million.

  • Emergent BioSolutions' Total Current Liabilities fell 40.63% to $136.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.5 million, marking a year-over-year decrease of 40.63%. This contributed to the annual value of $162.4 million for FY2024, which is 75.07% down from last year.
  • Emergent BioSolutions' Total Current Liabilities amounted to $136.5 million in Q3 2025, which was up 7.40% from $127.1 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Total Current Liabilities high stood at $1.2 billion for Q4 2022, and its period low was $111.9 million during Q1 2025.
  • In the last 3 years, Emergent BioSolutions' Total Current Liabilities had a median value of $619.7 million in 2024 and averaged $476.5 million.
  • Per our database at Business Quant, Emergent BioSolutions' Total Current Liabilities skyrocketed by 387.84% in 2023 and then crashed by 82.24% in 2025.
  • Emergent BioSolutions' Total Current Liabilities (Quarterly) stood at $374.0 million in 2021, then soared by 228.58% to $1.2 billion in 2022, then slumped by 47.00% to $651.3 million in 2023, then slumped by 75.07% to $162.4 million in 2024, then slumped by 40.63% to $136.5 million in 2025.
  • Its Total Current Liabilities stands at $136.5 million for Q3 2025, versus $127.1 million for Q2 2025 and $111.9 million for Q1 2025.